Trial Profile
A Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Alemtuzumab; Busulfan; Fludarabine
- Indications Myelodysplastic syndromes; Myeloid leukaemia
- Focus Adverse reactions
- 24 Sep 2019 Status changed from suspended to discontinued.
- 10 Oct 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 17 May 2012 New trial record